{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T08:27:19Z","timestamp":1793608039073,"version":"4.5.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100015956","name":"Special Project for Research and Development in Key areas of Guangdong Province","doi-asserted-by":"publisher","award":["2022B1111020002"],"award-info":[{"award-number":["2022B1111020002"]}],"id":[{"id":"10.13039\/501100015956","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.vaccine.2026.129137","type":"journal-article","created":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T02:57:23Z","timestamp":1789268243000},"page":"129137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys"],"prefix":"10.1016","volume":"92","author":[{"given":"Jianmin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cailing","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuankeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinlong","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuebaihe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuying","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2026.129137_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1128\/CVI.00662-14","article-title":"Long-term immunogenicity of an inactivated split-virion 2009 pandemic influenza a H1N1 virus vaccine with or without aluminum adjuvant in mice","volume":"22","author":"Xu","year":"2015","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129137_bb0010","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-0043-105850","article-title":"Der Mensch und Influenza \u2013 ein \u00fcberblick. [human and influenza - an overview]","volume":"72","author":"Frenzen","year":"2018","journal-title":"Pneumologie"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129137_bb0015","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1016\/j.vaccine.2024.04.054","article-title":"Cross-protective efficacy and safety of an adenovirus-based universal influenza vaccine expressing nucleoprotein, hemagglutinin, and the ectodomain of matrix protein 2","volume":"42","author":"Kim","year":"2024","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2026.129137_bb0020","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1016\/j.vaccine.2019.06.043","article-title":"Single-replication BM2SR vaccine provides sterilizing immunity and cross-lineage influenza B virus protection in mice","volume":"37","author":"Moser","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129137_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105639","article-title":"Development of MDCK-based quadrivalent split seasonal influenza virus vaccine with high safety and immunoprotection: a preclinical study","volume":"216","author":"Zhang","year":"2023","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129137_bb0030","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/21645515.2020.1780091","article-title":"Characterization of humoral and cellular immune features of gamma-irradiated influenza vaccine","volume":"17","author":"Chen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129137_bb0035","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-20-19","article-title":"Characterization of cross protection of swine-origin influenza virus (S-OIV) H1N1 and reassortant H5N1 influenza vaccine in BALB\/c mice given a single-dose vaccination","volume":"20","author":"Lin","year":"2013","journal-title":"J Biomed Sci"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129137_bb0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1750-2659.2009.00089.x","article-title":"Understanding influenza transmission, immunity and pandemic threats","volume":"3","author":"Mathews","year":"2009","journal-title":"Influenza Other Respi Viruses"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129137_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines10122131","article-title":"Longevity and mechanism of heterosubtypic protection induced by M2SR (M2-deficient single-replication) live influenza virus vaccine in mice","volume":"10","author":"Sarawar","year":"2022","journal-title":"Vaccines"},{"issue":"20","key":"10.1016\/j.vaccine.2026.129137_bb0050","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00969-18","article-title":"Complement C3 plays a key role in inducing humoral and cellular immune responses to influenza virus strain-specific hemagglutinin-based or cross-protective M2 extracellular domain-based vaccination","volume":"92","author":"Kim","year":"2018","journal-title":"J Virol"},{"issue":"15","key":"10.1016\/j.vaccine.2026.129137_bb0055","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00689-22","article-title":"A virion-based combination vaccine protects against influenza and SARS-CoV-2 disease in mice","volume":"96","author":"Chaparian","year":"2022","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129137_bb0060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41541-024-00980-3","article-title":"Preclinical immunogenicity and safety of hemagglutinin-encoding modRNA influenza vaccines","volume":"9","author":"Hauguel","year":"2024","journal-title":"NPJ Vaccines"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129137_bb0065","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1750-2659.2008.00053.x","article-title":"FluBlok, a recombinant hemagglutinin influenza vaccine","volume":"2","author":"Cox","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129137_bb0070","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02241-21","article-title":"A novel recombinant influenza virus neuraminidase vaccine candidate stabilized by a measles virus phosphoprotein tetramerization domain provides robust protection from virus challenge in the mouse model","volume":"12","author":"Strohmeier","year":"2021","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129137_bb0075","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-023-08541-0","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine compared with the trivalent vaccine for influenza infection: an overview of systematic reviews","volume":"23","author":"Carregaro","year":"2023","journal-title":"BMC Infect Dis"},{"issue":"22","key":"10.1016\/j.vaccine.2026.129137_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.05.056","article-title":"A quadrivalent recombinant influenza hemagglutinin vaccine induced strong protective immune responses in animal models","volume":"42","author":"Feng","year":"2024","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2026.129137_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines11101573","article-title":"Novel influenza vaccines: from research and development (R&D) challenges to regulatory responses","volume":"11","author":"He","year":"2023","journal-title":"Vaccines"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129137_bb0090","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1080\/21645515.2020.1737456","article-title":"Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models","volume":"16","author":"Ye","year":"2020","journal-title":"Hum Vaccin Immunother"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129137_bb0095","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/irv.12871","article-title":"Effectiveness of the MF59-adjuvanted trivalent or quadrivalent seasonal influenza vaccine among adults 65 years of age or older, a systematic review and meta-analysis","volume":"15","author":"Coleman","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2026.129137_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1043109","article-title":"New-age vaccine adjuvants, their development, and future perspective","volume":"14","author":"Verma","year":"2023","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129137_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007790","article-title":"MVA-based H5N1 vaccine affords cross-clade protection in mice against influenza a\/H5N1 viruses at low doses and after single immunization","volume":"4","author":"Kreijtz","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129137_bb0110","article-title":"Vaccination promotion strategies in the elderly: systematic review and meta-analysis","volume":"12","author":"Pereira","year":"2024","journal-title":"Vaccines (Basel)."},{"issue":"45","key":"10.1016\/j.vaccine.2026.129137_bb0115","doi-asserted-by":"crossref","first-page":"8147","DOI":"10.1016\/j.vaccine.2011.08.027","article-title":"Efficacy of a vaccine that links viral epitopes to flagellin in protecting aged mice from influenza viral infection","volume":"29","author":"Leng","year":"2011","journal-title":"Vaccine"},{"issue":"1711","key":"10.1016\/j.vaccine.2026.129137_bb0120","doi-asserted-by":"crossref","first-page":"145","DOI":"10.58347\/tml.2024.1711a","article-title":"Influenza vaccine for 2024-2025","volume":"66","year":"2024","journal-title":"Med Lett Drugs Ther"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129137_bb0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.4140\/TCP.n.2023.156","article-title":"Efficacy of the adjuvanted influenza vaccine compared with the high-dose for older people","volume":"38","author":"Morse","year":"2023","journal-title":"Sr Care Pharm"},{"key":"10.1016\/j.vaccine.2026.129137_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112239","article-title":"SARS-CoV-2 inactivated vaccine (Vero cells) shows good safety in repeated administration toxicity test of Sprague Dawley rats","volume":"152","author":"Huang","year":"2021","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"10.1016\/j.vaccine.2026.129137_bb0135","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/jat.3314","article-title":"Dose site reactions and related findings after vaccine administration in safety studies","volume":"36","author":"Baldrick","year":"2016","journal-title":"J Appl Toxicol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129137_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.vaccine.2018.07.036","article-title":"Immunogenicity and safety of a quadrivalent inactivated influenza vaccine in children 6-59months of age: a phase 3, randomized, noninferiority study","volume":"37","author":"Statler","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129137_bb0145","doi-asserted-by":"crossref","unstructured":"van de Witte S, Nauta J, Montomoli E, et al. A phase III randomised trial of the - 49 - immunogenicity and safety of quadrivalent versus trivalent inactivated subunit influenza vaccine in adult and elderly subjects, assessing both anti-haemagglutinin and virus neutralisation antibody responses. Vaccine, 36(40), 6030\u20136038. Doi:https:\/\/doi.org\/10.1016\/j.vaccine.2018.04.043.","DOI":"10.1016\/j.vaccine.2018.04.043"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129137_bb0150","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1515\/biol-2022-0478","article-title":"Preclinical immunogenicity assessment of a cell-based inactivated whole-virion H5N1 influenza vaccine","volume":"17","author":"Zhang","year":"2022","journal-title":"Open Life Sci"},{"key":"10.1016\/j.vaccine.2026.129137_bb0155","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2463731","article-title":"High-titre neutralizing antibodies to H1N1 influenza virus after mouse immunization with yeast expressed H1 antigen: a promising influenza vaccine candidate","volume":"2019","author":"Kopera","year":"2019","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129137_bb0160","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmv.10540","article-title":"Aggregate content influences the Th1\/Th2 immune response to influenza vaccine: evidence from a mouse model","volume":"72","author":"Babiuk","year":"2004","journal-title":"J Med Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129137_bb0165","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4149\/av_2020_314","article-title":"Pathological and immunological protection induced by inactivated reverse genetics-based H3N8 equine influenza vaccine candidate in murine model","volume":"64","author":"Kumar","year":"2020","journal-title":"Acta Virol"},{"issue":"12","key":"10.1016\/j.vaccine.2026.129137_bb0170","article-title":"Cell-cultured influenza vaccine enhances IFN-\u03b3+ T cell and memory T cell responses following a\/Victoria\/2570\/2019 IVR-215 (a\/H1N1) infection","volume":"12","author":"Kang","year":"2024","journal-title":"Vaccines (Basel)"},{"issue":"35","key":"10.1016\/j.vaccine.2026.129137_bb0175","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1016\/j.vaccine.2016.06.064","article-title":"Immunogenicity and safety of inactivated quadrivalent influenza vaccine in adults: a systematic review and meta-analysis of randomised controlled trials","volume":"34","author":"Moa","year":"2016","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129137_bb0180","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1586\/14760584.2016.1113878","article-title":"Evidence update: GlaxoSmithKline\u2019s inactivated quadrivalent influenza vaccines","volume":"15","author":"Bekkat-Berkani","year":"2016","journal-title":"Expert Rev Vaccines"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26009461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T07:40:46Z","timestamp":1793605246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26009461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":36,"alternative-id":["S0264410X26009461"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129137","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preclinical toxicity and immunogenicity of a quadrivalent recombinant influenza hemagglutinin vaccine (SCVC101) in rhesus monkeys","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129137","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129137"}}